Ritonavir (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ritonavir" in Romanian language version.

refsWebsite

Global rank Romanian rank

7web.archive.org

1^st place

7nih.gov

4^th place

6doi.org

2^nd place

3^rd place

3fda.gov

447^th place

173^rd place

2ebi.ac.uk

5,849^th place

138^th place

2drugs.com

399^th place

157^th place

2worldcat.org

5^th place

11^th place

1cas.org

8,332^nd place

310^th place

1chemspider.com

8,573^rd place

247^th place

1drugbank.com

low place

160^th place

1books.google.com

3^rd place

6^th place

1google.ca

838^th place

285^th place

1mshpriceguide.org

low place

1rxlist.com

7,927^th place

5,692^nd place

1merck.com

6,464^th place

low place

1archives-ouvertes.fr

1,031^st place

6,454^th place

1oxfordjournals.org

1,389^th place

452^nd place

archives-ouvertes.fr

hal.archives-ouvertes.fr

Nieminen, Tuija H.; Hagelberg, Nora M.; Saari, Teijo I.; Neuvonen, Mikko; Neuvonen, Pertti J.; Laine, Kari; Olkkola, Klaus T. (2010). „Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir”. European Journal of Clinical Pharmacology. 66 (10): 977–985. doi:10.1007/s00228-010-0879-1. ISSN 0031-6970. PMID 20697700.

books.google.com

Hacker, Miles (2009). Pharmacology principles and practice. Amsterdam: Academic Press/Elsevier. p. 550. ISBN 9780080919225.

cas.org

commonchemistry.cas.org

CAS Common Chemistry, accesat în 10 aprilie 2021

chemspider.com

Ritonavir (în engleză), ChemSpider, accesat în 18 noiembrie 2016

doi.org

Henry, J. A.; Hill, I. R. (1998). „Fatal interaction between ritonavir and MDMA”. Lancet. 352 (9142): 1751–1752. doi:10.1016/s0140-6736(05)79824-x. PMID 9848354.
Papaseit, E.; Vázquez, A.; Pérez-Mañá, C.; Pujadas, M.; De La Torre, R.; Farré, M.; Nolla, J. (2012). „Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)”. Intensive Care Medicine. 38 (7): 1239–1240. doi:10.1007/s00134-012-2537-9. PMID 22460853.
Nieminen, Tuija H.; Hagelberg, Nora M.; Saari, Teijo I.; Neuvonen, Mikko; Neuvonen, Pertti J.; Laine, Kari; Olkkola, Klaus T. (2010). „Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir”. European Journal of Clinical Pharmacology. 66 (10): 977–985. doi:10.1007/s00228-010-0879-1. ISSN 0031-6970. PMID 20697700.
Hsieh, Yi-Ling; Ilevbare, Grace A.; Van Eerdenbrugh, Bernard; Box, Karl J.; Sanchez-Felix, Manuel Vincente; Taylor, Lynne S. (12 mai 2012). „pH-Induced Precipitation Behavior of Weakly Basic Compounds: Determination of Extent and Duration of Supersaturation Using Potentiometric Titration and Correlation to Solid State Properties”. Pharmaceutical Research (în engleză). 29 (10): 2738–2753. doi:10.1007/s11095-012-0759-8. ISSN 0724-8741. PMID 22580905.
„Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients”. Journal of Antimicrobial Chemotherapy. 53 (1): 4–9. 2004. doi:10.1093/jac/dkh029. PMID 14657084. Arhivat din original la 21 august 2007.
Cao, Bin; Wang, Yeming; Wen, Danning; Liu, Wen; Wang, Jingli; Fan, Guohui; Ruan, Lianguo; Song, Bin; Cai, Yanping (18 martie 2020). „A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19”. New England Journal of Medicine. doi:10.1056/NEJMoa2001282. PMID 32187464.

drugbank.com

Ritonavir (în engleză), DrugBank, 17 noiembrie 2015

drugs.com

„Ritonavir”. The American Society of Health-System Pharmacists. Arhivat din original la 17 octombrie 2015. Accesat în 23 d.Hr..
„Ritonavir Pregnancy and Breastfeeding Warnings”. drugs.com. Arhivat din original la 7 septembrie 2015. Accesat în 23 octombrie 2015.

ebi.ac.uk

ritonavir (în engleză), ChEBI, accesat în 19 octombrie 2016
RITONAVIR (în engleză), ChEMBL, accesat în 18 noiembrie 2016

fda.gov

ritonavir (în engleză), Global Substance Registration System, accesat în 18 noiembrie 2016
„FDA approves Viekira Pak to treat hepatitis C”. Food and Drug Administration. 19 decembrie 2014. Arhivat din original la 31 octombrie 2015.
Research, Center for Drug Evaluation and (3 decembrie 2019). „Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers”. FDA.

google.ca

books.google.ca

Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery (în engleză). John Wiley & Sons. p. 509. ISBN 9783527607495.

merck.com

„Ritonavir: Drug Information Provided by Lexi-Comp: Merck Manual Professional”. 30 aprilie 2008. Arhivat din original la 30 aprilie 2008.

mshpriceguide.org

„Ritonavir”. International Drug Price Indicator Guide. Arhivat din original la 10 mai 2017. Accesat în 23 octombrie 2015.

nih.gov

ncbi.nlm.nih.gov

Henry, J. A.; Hill, I. R. (1998). „Fatal interaction between ritonavir and MDMA”. Lancet. 352 (9142): 1751–1752. doi:10.1016/s0140-6736(05)79824-x. PMID 9848354.
Papaseit, E.; Vázquez, A.; Pérez-Mañá, C.; Pujadas, M.; De La Torre, R.; Farré, M.; Nolla, J. (2012). „Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)”. Intensive Care Medicine. 38 (7): 1239–1240. doi:10.1007/s00134-012-2537-9. PMID 22460853.
Nieminen, Tuija H.; Hagelberg, Nora M.; Saari, Teijo I.; Neuvonen, Mikko; Neuvonen, Pertti J.; Laine, Kari; Olkkola, Klaus T. (2010). „Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir”. European Journal of Clinical Pharmacology. 66 (10): 977–985. doi:10.1007/s00228-010-0879-1. ISSN 0031-6970. PMID 20697700.
Hsieh, Yi-Ling; Ilevbare, Grace A.; Van Eerdenbrugh, Bernard; Box, Karl J.; Sanchez-Felix, Manuel Vincente; Taylor, Lynne S. (12 mai 2012). „pH-Induced Precipitation Behavior of Weakly Basic Compounds: Determination of Extent and Duration of Supersaturation Using Potentiometric Titration and Correlation to Solid State Properties”. Pharmaceutical Research (în engleză). 29 (10): 2738–2753. doi:10.1007/s11095-012-0759-8. ISSN 0724-8741. PMID 22580905.
„Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients”. Journal of Antimicrobial Chemotherapy. 53 (1): 4–9. 2004. doi:10.1093/jac/dkh029. PMID 14657084. Arhivat din original la 21 august 2007.
Cao, Bin; Wang, Yeming; Wen, Danning; Liu, Wen; Wang, Jingli; Fan, Guohui; Ruan, Lianguo; Song, Bin; Cai, Yanping (18 martie 2020). „A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19”. New England Journal of Medicine. doi:10.1056/NEJMoa2001282. PMID 32187464.

pubchem.ncbi.nlm.nih.gov

„Ritonavir”, ritonavir (în engleză), PubChem, accesat în 18 noiembrie 2016

oxfordjournals.org

jac.oxfordjournals.org

„Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients”. Journal of Antimicrobial Chemotherapy. 53 (1): 4–9. 2004. doi:10.1093/jac/dkh029. PMID 14657084. Arhivat din original la 21 august 2007.

rxlist.com

„Norvir side effects (Ritonavir) and drug interactions - prescription drugs and medications at RxList”. 27 iunie 2007. Arhivat din original la 27 iunie 2007.

web.archive.org

„Ritonavir”. The American Society of Health-System Pharmacists. Arhivat din original la 17 octombrie 2015. Accesat în 23 d.Hr..
„FDA approves Viekira Pak to treat hepatitis C”. Food and Drug Administration. 19 decembrie 2014. Arhivat din original la 31 octombrie 2015.
„Ritonavir Pregnancy and Breastfeeding Warnings”. drugs.com. Arhivat din original la 7 septembrie 2015. Accesat în 23 octombrie 2015.
„Ritonavir”. International Drug Price Indicator Guide. Arhivat din original la 10 mai 2017. Accesat în 23 octombrie 2015.
„Norvir side effects (Ritonavir) and drug interactions - prescription drugs and medications at RxList”. 27 iunie 2007. Arhivat din original la 27 iunie 2007.
„Ritonavir: Drug Information Provided by Lexi-Comp: Merck Manual Professional”. 30 aprilie 2008. Arhivat din original la 30 aprilie 2008.
„Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients”. Journal of Antimicrobial Chemotherapy. 53 (1): 4–9. 2004. doi:10.1093/jac/dkh029. PMID 14657084. Arhivat din original la 21 august 2007.

worldcat.org

Nieminen, Tuija H.; Hagelberg, Nora M.; Saari, Teijo I.; Neuvonen, Mikko; Neuvonen, Pertti J.; Laine, Kari; Olkkola, Klaus T. (2010). „Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir”. European Journal of Clinical Pharmacology. 66 (10): 977–985. doi:10.1007/s00228-010-0879-1. ISSN 0031-6970. PMID 20697700.
Hsieh, Yi-Ling; Ilevbare, Grace A.; Van Eerdenbrugh, Bernard; Box, Karl J.; Sanchez-Felix, Manuel Vincente; Taylor, Lynne S. (12 mai 2012). „pH-Induced Precipitation Behavior of Weakly Basic Compounds: Determination of Extent and Duration of Supersaturation Using Potentiometric Titration and Correlation to Solid State Properties”. Pharmaceutical Research (în engleză). 29 (10): 2738–2753. doi:10.1007/s11095-012-0759-8. ISSN 0724-8741. PMID 22580905.